Organogenesis Investor Relations Material
Latest events
Q4 2024
Organogenesis
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Organogenesis Holdings Inc
Access all reports
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of products for the advanced wound care and surgical biologics markets. The company's portfolio includes skin substitutes and other tissue-based products designed to promote healing and tissue regeneration. Organogenesis serves healthcare providers, offering solutions for the treatment of chronic and acute wounds, as well as products used in surgical and sports medicine applications. The company is headquartered in Canton, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ORGO
Country
🇺🇸 United States